Clindacin P Solution
Pricing Report NDC 43538-170-69

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The latest wholesale acquisition cost for Clindacin P (NDC 43538-170-69) is $8.94325 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jul 31, 2020.

As a a human prescription drug provided by Eurofarma, Inc., this medication is distributed in a 69 APPLICATOR in 1 JAR / 1 mL in 1 APPLICATOR configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$8.94325
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Jul 31, 2020
Billable Units
1 EA
Estimated Package Price
$8.94
Data Status
As of Jul 14, 2021
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B-ANDA - Abbreviated New Drug Application
Package NDC
43538-170-69
Description
69 APPLICATOR in 1 JAR / 1 mL in 1 APPLICATOR
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The NADAC was calculated based on package size.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Sep 2014, the NADAC wholesale price for (NDC ) has moved within a range of $3.93389 to $8.94325 per EA. Over this 5 years and 10 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$3.9339 - $8.9433
Market Volatility
127.34% Variance
Latest Trend
6.60%
Date Unit Price Unit Source Method Rate
Jul 31, 2020 $8.94325 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Jul 31, 2020 $8.94325 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Sep 19, 2019 $8.38954 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Sep 19, 2019 $8.38954 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Jun 28, 2019 $7.69676 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Jun 28, 2019 $7.69676 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Mar 01, 2019 $7.29806 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Mar 01, 2019 $7.29806 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Aug 31, 2018 $6.97918 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Aug 31, 2018 $6.97918 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 29, 2017 $6.79233 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 29, 2017 $6.79233 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
May 09, 2017 $6.54146 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
May 09, 2017 $6.54146 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Mar 31, 2017 $6.31415 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Mar 31, 2017 $6.31415 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Aug 30, 2016 $6.09474 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Aug 30, 2016 $6.09474 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Apr 04, 2016 $5.88307 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Apr 04, 2016 $5.88307 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Jan 01, 2016 $5.16185 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Jan 01, 2016 $5.16185 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Jul 21, 2015 $4.82416 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Jul 21, 2015 $4.82416 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
May 26, 2015 $4.50856 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
May 26, 2015 $4.50856 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Apr 13, 2015 $4.44412 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Apr 13, 2015 $4.44412 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 20, 2014 $4.29384 EAC/I - Chain or Independent PharmacyCode 3, 5, 6B-ANDA - Abbreviated New Drug Application
Dec 20, 2014 $4.29384 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application
Sep 17, 2014 $3.93389 EAC/I - Chain or Independent PharmacyCode 1, 5, 6B-ANDA - Abbreviated New Drug Application
Sep 17, 2014 $3.93389 EAC/I - Chain or Independent PharmacyCode 4, 5, 6B-ANDA - Abbreviated New Drug Application

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026